(Alliance News) - Proteome Sciences PLC on Friday reported stable sales in the first five months of 2020 and said it expects "this positive trend" to continue for the reminder of the year.
Ahead of its annual general meeting, the science research company reported continued progress throughout the business after delivering profit after tax in 2019.
Proteome Sciences said it has experienced good growth in services revenue and sales of both TMT and TMTpro have remained stable over the first five months of 2020.
"Despite the challenges of the Covid-19 pandemic, our dedicated staff have ensured we remained fully operational and have delivered 11 projects carried over from 2019 for which we already had samples," said Chair Christopher Pearce.
A further 10 projects are ongoing and new orders are also being generated, Proteome Sciences noted.
"We expect these positive trends to continue through the rest of the year," added Pearce.
AIM-listed Proteome Sciences shares were trading 6.5% lower in London on Friday afternoon at 3.50 pence each.
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
Proteome (PRM)